D
David R. Thiemann
Researcher at Johns Hopkins University School of Medicine
Publications - 44
Citations - 6191
David R. Thiemann is an academic researcher from Johns Hopkins University School of Medicine. The author has contributed to research in topics: Heart failure & Population. The author has an hindex of 22, co-authored 39 publications receiving 5584 citations. Previous affiliations of David R. Thiemann include Johns Hopkins University.
Papers
More filters
Journal ArticleDOI
Neurohumoral Features of Myocardial Stunning Due to Sudden Emotional Stress
Ilan S. Wittstein,David R. Thiemann,Joao A.C. Lima,Kenneth L. Baughman,Steven P. Schulman,Gary Gerstenblith,Katherine C. Wu,Jeffrey J. Rade,Trinity J. Bivalacqua,Hunter C. Champion +9 more
TL;DR: Emotional stress can precipitate severe, reversible left ventricular dysfunction in patients without coronary disease andaggerated sympathetic stimulation is probably central to the cause of this syndrome.
Journal ArticleDOI
Late Gadolinium Enhancement by Cardiovascular Magnetic Resonance Heralds an Adverse Prognosis in Nonischemic Cardiomyopathy
Katherine C. Wu,Robert G. Weiss,David R. Thiemann,Kakuya Kitagawa,André Schmidt,Darshan Dalal,Shenghan Lai,David A. Bluemke,Gary Gerstenblith,Eduardo Marbán,Gordon F. Tomaselli,Joao A.C. Lima +11 more
TL;DR: The CMR LGE may represent the end-organ consequences of sustained adrenergic activation and adverse LV remodeling, and its identification may significantly improve risk stratification strategies in this high risk population.
Journal ArticleDOI
A randomized trial of the efficacy of multidisciplinary care in heart failure outpatients at high risk of hospital readmission
Edward K. Kasper,Gary Gerstenblith,Gail Hefter,Elizabeth Van Anden,Jeffrey A. Brinker,David R. Thiemann,Michael L. Terrin,Sandra A. Forman,Sheldon H. Gottlieb +8 more
TL;DR: This study demonstrates that a six-month, multidisciplinary approach to CHF management can improve important clinical outcomes at a similar cost in recently hospitalized high-risk patients with CHF.
Journal ArticleDOI
Pulmonary Capillary Wedge Pressure Augments Right Ventricular Pulsatile Loading
Ryan J. Tedford,Paul M. Hassoun,Stephen C. Mathai,Reda E. Girgis,Stuart D. Russell,David R. Thiemann,Oscar H. Cingolani,James O. Mudd,Barry A. Borlaug,Margaret M. Redfield,David J. Lederer,David A. Kass +11 more
TL;DR: Pulmonary hypertension and pulmonary fibrosis do not significantly change the hyperbolic dependence between RPA and CPA, and patient age has only minimal effects, which helps explain the difficulty of reducing total right ventricular afterload by therapies that have a modest impact on mean RPA.
Journal ArticleDOI
Lack of Benefit for Intravenous Thrombolysis in Patients With Myocardial Infarction Who Are Older Than 75 Years
David R. Thiemann,Josef Coresh,Steven P. Schulman,Gary Gerstenblith,William J. Oetgen,Neil R. Powe +5 more
TL;DR: In nationwide clinical practice, thrombolytic therapy for patients >75 years old is unlikely to confer survival benefit and may have a significant survival disadvantage.